Top Pharmaceuticals stocks in United States
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $690.55bn | 72.14 | 0.62% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $356.43bn | 16.21 | 3.22% |
MRKMerck & Co | $318.60bn | 91.93 | 2.35% |
ABBVAbbvie | $294.65bn | 36.63 | 3.56% |
PFEPfizer | $147.23bn | 8.12 | 6.31% |
AMGNAmgen | $144.25bn | 21.03 | 3.17% |
CELG RTBristol-Myers Squibb Co | $99.17bn | 0.02 | 4000% |
BMYBristol-Myers Squibb Co | $99.17bn | 13.05 | 4.66% |
GILDGilead Sciences | $83.25bn | 11.52 | 4.49% |
MCKMcKesson | $68.97bn | 23.32 | 0.43% |
ZTSZoetis | $66.94bn | 28.38 | 1.02% |
BIIBBiogen | $28.26bn | 20.85 | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $26.32bn | 22.72 | 1.84% |
RPRXRoyalty Pharma | $16.83bn | 11.11 | 2.84% |
BMRNBiomarin Pharmaceutical | $16.82bn | 89.64 | n/a |
VTRSViatris | $13.36bn | 20.96 | 4.27% |
INCYIncyte | $11.75bn | 19.08 | n/a |
CTLTCatalent | $10.04bn | n/a | n/a |